Shandong Sito Bio-technology Co Ltd (300583) — Capital Reinvestment Ratio
Shandong Sito Bio-technology Co Ltd (300583) has a Capital Reinvestment Ratio of 0.71x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.13 Million) in capital expenditures (CN¥10.75 Million). See Shandong Sito Bio-technology Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Sito Bio-technology Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Shandong Sito Bio-technology Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Check 300583 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Sito Bio-technology Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Shandong Sito Bio-technology Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see market value of Shandong Sito Bio-technology Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | CN¥194.46 Million | CN¥65.53 Million | ▼ -65.9% |
| 2022 | 0.99x | CN¥145.34 Million | CN¥143.68 Million | ▼ -42.2% |
| 2021 | 1.71x | CN¥227.35 Million | CN¥388.92 Million | ▲ +79.5% |
| 2020 | 0.95x | CN¥254.60 Million | CN¥242.60 Million | ▼ -73.9% |
| 2019 | 3.66x | CN¥57.62 Million | CN¥210.73 Million | ▼ -47.1% |
| 2017 | 6.91x | CN¥10.90 Million | CN¥75.34 Million | ▲ +340.3% |
| 2016 | 1.57x | CN¥80.15 Million | CN¥125.87 Million | ▲ +4.7% |
| 2015 | 1.50x | CN¥87.10 Million | CN¥130.67 Million | ▲ +14.1% |
| 2014 | 1.31x | CN¥174.49 Million | CN¥229.42 Million | ▼ -29.5% |
| 2013 | 1.87x | CN¥24.95 Million | CN¥46.55 Million | — |